Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DMNB Adopts DNASTAR Lasergene Software

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
New Lasergene software site license agreement for genome sequence assembly and analysis.

DNASTAR has announced that Dalhousie Medicine New Brunswick (DMNB) has entered into an agreement supporting an enterprise-wide site license of DNASTAR Lasergene software for genome sequence assembly and analysis.

The license provides access to the DNASTAR software for all faculty, staff and students of DMNB.

Dr. Keith Brunt, assistant professor at Dalhousie Medicine New Brunswick said, “Until we entered into this agreement, we didn’t have much experience with DNASTAR or their Lasergene software. The more time we spent using the software and the more we learned about its capabilities, the more impressed we were with it. By signing this agreement, we provide access to outstanding software for all of our scientists, faculty, staff and students at a very reasonable cost. This software will help in the training of a new generation of physicians and is a step toward patient tailored therapy. This agreement will help support the future success and growth of our program.”

Tom Schwei, Vice President and General Manager of DNASTAR, stated, “We are pleased to have entered into this agreement with Dalhousie Medicine New Brunswick. Our company was founded from an academic research environment and we continue to focus on ensuring we are serving the academic market well. We are particularly pleased to have DMNB as a customer, as their focus on medicine correlates well with a growing area of focus for our future software development. We appreciate the trust placed in our tools and company by DMNB’s management and we look forward to continuing to meet the organization’s sequence assembly and analysis software needs in the future.”

Financial terms of the arrangement were not disclosed.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wellcome Trust Sanger Institute Adopts DNASTAR Lasergene Software
Wellcome Trust Sanger Institute and DNASTAR have entered into a multi-year software license agreement.
Thursday, December 05, 2013
DNASTAR Awarded Antibody Engineering SBIR Grant
NIH awarded grant to build antibody engineering software.
Tuesday, May 15, 2012
DNASTAR Partners with Ion Torrent
Ion Torrent offers DNASTAR’s sequence assembly and analysis software products to the customers through the Ion Torrent on-line web store in the collaboration.
Wednesday, February 16, 2011
DNASTAR Joins BioIT Alliance
BioIT Alliance announces the expansion of the BioIT Alliance program to include DNASTAR.
Thursday, January 28, 2010
DNASTAR and the University of Iowa Sign Lasergene Site License Agreement
Researchers on the University of Iowa campus have gained unlimited access and use of the software for their sequence analysis projects.
Wednesday, January 06, 2010
Wageningen University and DNASTAR Extend Lasergene Site License Agreement
Under the terms of the site license, researchers will have unlimited use of the software for their sequence analysis projects.
Tuesday, November 24, 2009
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!